Breast Cancer Liquid Biopsy Market Report 2026
Download Free Sample Buy Now
Breast Cancer Liquid Biopsy Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Breast Cancer Liquid Biopsy Market Report 2026

Global Outlook – By Product (Consumables, Kits), By Biomarkers (Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), Circulating Tumor RNA (ctRNA), Circulating Tumor Cells (CTCs), Cell-free RNA (cfRNA), Other Biomarkers), By Application (Early Detection Or Screening, Diagnosis, Other Applications), By End Users (Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Breast Cancer Liquid Biopsy Market Overview

• Breast Cancer Liquid Biopsy market size has reached to $0.89 billion in 2025

• Expected to grow to $1.75 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%

• Growth Driver: Rising Breast Cancer Cases Fuel Demand For Advanced Diagnostics

• Market Trend: Advancements In Companion Diagnostics For Personalized Cancer Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Breast Cancer Liquid Biopsy Market?

A breast cancer liquid biopsy is a minimally invasive test that detects and analyzes tumor-derived materials in a patient’s blood or other bodily fluids. It provides valuable insights into the presence, progression, and genetic profile of breast cancer without requiring a traditional tissue biopsy.

The main products of breast cancer liquid biopsy are consumables and kits. Breast cancer liquid biopsy consumables refer to the disposable materials, reagents, and kits used during the process of conducting liquid biopsy tests for detecting and analyzing biomarkers associated with breast cancer. The various biomarkers include extracellular vesicles (EVS), cell-free dna (cfDNA), circulating tumor RNA (ctRNA), circulating tumor cells (CTCS), cell-free RNA (cfRNA), and others, and several applications including early detection or screening, diagnosis, and others. The different end users encompass laboratories, hospitals, physician laboratories, reference laboratories, public health laboratories, research institutes, small molecular laboratories, and pathology laboratories.

Breast Cancer Liquid Biopsy market report bar graph

What Is The Breast Cancer Liquid Biopsy Market Size and Share 2026?

The breast cancer liquid biopsy market size has grown rapidly in recent years. It will grow from $0.89 billion in 2025 to $1.02 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to rising breast cancer prevalence, limitations of tissue biopsy, oncology diagnostic advancements, increased screening awareness, laboratory testing expansion.

What Is The Breast Cancer Liquid Biopsy Market Growth Forecast?

The breast cancer liquid biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.75 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to precision oncology adoption, AI-based mutation analysis, personalized treatment planning, growth in cfDNA testing, decentralized cancer diagnostics. Major trends in the forecast period include multi-biomarker blood-based testing, non-invasive cancer monitoring, treatment response tracking, early recurrence detection, personalized oncology diagnostics.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Breast Cancer Liquid Biopsy Market Segmentation

1) By Product: Consumables, Kits

2) By Biomarkers: Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), Circulating Tumor RNA (ctRNA), Circulating Tumor Cells (CTCs), Cell-free RNA (cfRNA), Other Biomarkers

3) By Application: Early Detection Or Screening, Diagnosis, Other Applications

4) By End Users: Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories

Subsegments:

1) By Consumables: Reagents, Polymerase Chain Reaction (PCR) Assays, Sequencing Panels, Sample Collection Tubes

2) By Kits: DNA-based Liquid Biopsy Kits, RNA-based Liquid Biopsy Kits, Multi-marker Liquid Biopsy Kits

What Is The Driver Of The Breast Cancer Liquid Biopsy Market?

The increase in breast cancer cases is expected to propel the growth of the breast cancer liquid biopsy market going forward. Breast cancer is a type of cancer that develops in the cells of the breast, typically in the lobules (milk-producing glands) or ducts (pathways that carry milk to the nipple). Breast cancer cases are on the rise due to factors including genetic predisposition, hormonal imbalances, aging population, lifestyle changes, obesity, alcohol consumption, lack of physical activity, exposure to radiation, and environmental pollutants. A breast cancer liquid biopsy is used in treatment to detect circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) in the blood, helping to monitor the disease in real-time. It aids in assessing treatment response, detecting therapy resistance, and identifying genetic mutations for targeted therapies. For instance, in 2025, according to the American Cancer Society, a US-based nonprofit organization dedicated to cancer research, education, advocacy, and patient support, the number of new breast cancer cases is expected to rise to 319,750 in 2025, up from 313,510 cases in 2024. Therefore, the increase in breast cancer cases is driving the growth of the breast cancer liquid biopsy industry.

Key Players In The Global Breast Cancer Liquid Biopsy Market

Major companies operating in the breast cancer liquid biopsy market are Johnson & Johnson Private Limited, Roche Diagnostics, Merck KGaA, Thermo Fisher Scientific, Siemens Healthineers, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Myriad Genetics Inc., NeoGenomics Laboratories, Guardant Health Inc., Twist Bioscience, Foundation Medicine Inc., Biodesix Inc., Menarini Silicon Biosystems, Datar Cancer Genetics, Abcam plc, OncoDNA SA, Genomic Health Inc., RainDance Technologies, Biocept Inc., Fluxion Biosciences Inc., Angle plc

Global Breast Cancer Liquid Biopsy Market Trends and Insights

Major companies operating in the breast cancer liquid biopsy market are focusing on developing innovative products, such as companion diagnostics, to enable personalized treatment approaches by identifying patients who benefit from specific therapies. Companion diagnostics utilize liquid biopsy technologies to detect biomarkers such as genetic mutations, circulating tumor DNA (ctDNA), or protein expressions indicative of treatment responsiveness. For instance, in January 2023, Guardant Health Inc., a US-based biotechnology company, received Food and Drug Administration (FDA) approval for its Guardant360 CDx liquid biopsy test as a companion diagnostic for Menarini Group’s ORSERDU (elacestrant), a treatment for advanced or metastatic breast cancer patients with ESR1 mutations. This approval enables oncologists to use the test for comprehensive genomic profiling, identifying patients who may benefit from the targeted therapy. It marks Guardant Health’s first U.S. Food and Drug Administration (FDA) approval in breast cancer and expands its role in precision oncology.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Breast Cancer Liquid Biopsy Market?

In January 2024, Guardant Health Inc., a US-based biotechnology company dedicated to conquering cancer through liquid biopsies, partnered with Hikma Pharmaceuticals plc. With this collaboration, Hikma seeks to enhance early cancer detection, monitor recurrence, and optimize treatment selection using Guardant Health’s cutting-edge liquid and tissue biopsy technologies. This partnership strengthens Guardant’s global reach, tackling the growing cancer challenge in the Middle East and North Africa. Hikma Pharmaceuticals plc is a UK-based pharmaceutical company.

Regional Outlook

North America was the largest region in the breast cancer liquid biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Breast Cancer Liquid Biopsy Market?

The breast cancer liquid biopsy market consists of revenues earned by entities by providing services such as early cancer detection, treatment monitoring, minimal residual disease (MRD) detection, recurrence prediction, and genetic mutation analysis for targeted therapy selection. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast cancer liquid biopsy market also includes sales of circulating tumor DNA (ctDNA) assay kits, circulating tumor cell (CTC) detection systems, next-generation sequencing (NGS) panels, PCR-based liquid biopsy tests, blood collection tubes, and consumables and reagents used for non-invasive cancer diagnostics and monitoring. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Breast Cancer Liquid Biopsy Market Report 2026?

The breast cancer liquid biopsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the breast cancer liquid biopsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Breast Cancer Liquid Biopsy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.02 billion
Revenue Forecast In 2035 $1.75 billion
Growth Rate CAGR of 14.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Biomarkers, Application, End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson & Johnson Private Limited, Roche Diagnostics, Merck KGaA, Thermo Fisher Scientific, Siemens Healthineers, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Myriad Genetics Inc., NeoGenomics Laboratories, Guardant Health Inc., Twist Bioscience, Foundation Medicine Inc., Biodesix Inc., Menarini Silicon Biosystems, Datar Cancer Genetics, Abcam plc, OncoDNA SA, Genomic Health Inc., RainDance Technologies, Biocept Inc., Fluxion Biosciences Inc., Angle plc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Breast Cancer Liquid Biopsy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Breast Cancer Liquid Biopsy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Breast Cancer Liquid Biopsy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Breast Cancer Liquid Biopsy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Multi-Biomarker Blood-Based Testing

4.2.2 Non-Invasive Cancer Monitoring

4.2.3 Treatment Response Tracking

4.2.4 Early Recurrence Detection

4.2.5 Personalized Oncology Diagnostics

5. Breast Cancer Liquid Biopsy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Physician Laboratories

5.4 Research Institutes

5.5 Pathology Laboratories

6. Breast Cancer Liquid Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Breast Cancer Liquid Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Breast Cancer Liquid Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Breast Cancer Liquid Biopsy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Breast Cancer Liquid Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Breast Cancer Liquid Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Breast Cancer Liquid Biopsy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Breast Cancer Liquid Biopsy Market Segmentation

9.1. Global Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Consumables, Kits

9.2. Global Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Extracellular Vesicles (EVs), Cell-free DNA (cfDNA), Circulating Tumor RNA (ctRNA), Circulating Tumor Cells (CTCs), Cell-free RNA (cfRNA), Other Biomarkers

9.3. Global Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early Detection Or Screening, Diagnosis, Other Applications

9.4. Global Breast Cancer Liquid Biopsy Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Laboratories, Hospitals, Physician Laboratories, Reference Laboratories, Public Health Laboratories, Research Institutes, Small Molecular Laboratories, Pathology Laboratories

9.5. Global Breast Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Reagents, Polymerase Chain Reaction (PCR) Assays, Sequencing Panels, Sample Collection Tubes

9.6. Global Breast Cancer Liquid Biopsy Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA-based Liquid Biopsy Kits, RNA-based Liquid Biopsy Kits, Multi-marker Liquid Biopsy Kits

10. Breast Cancer Liquid Biopsy Market Regional And Country Analysis

10.1. Global Breast Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Breast Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Breast Cancer Liquid Biopsy Market

11.1. Asia-Pacific Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Breast Cancer Liquid Biopsy Market

12.1. China Breast Cancer Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Breast Cancer Liquid Biopsy Market

13.1. India Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Breast Cancer Liquid Biopsy Market

14.1. Japan Breast Cancer Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Breast Cancer Liquid Biopsy Market

15.1. Australia Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Breast Cancer Liquid Biopsy Market

16.1. Indonesia Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Breast Cancer Liquid Biopsy Market

17.1. South Korea Breast Cancer Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Breast Cancer Liquid Biopsy Market

18.1. Taiwan Breast Cancer Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Breast Cancer Liquid Biopsy Market

19.1. South East Asia Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Breast Cancer Liquid Biopsy Market

20.1. Western Europe Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Breast Cancer Liquid Biopsy Market

21.1. UK Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Breast Cancer Liquid Biopsy Market

22.1. Germany Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Breast Cancer Liquid Biopsy Market

23.1. France Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Breast Cancer Liquid Biopsy Market

24.1. Italy Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Breast Cancer Liquid Biopsy Market

25.1. Spain Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Breast Cancer Liquid Biopsy Market

26.1. Eastern Europe Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Breast Cancer Liquid Biopsy Market

27.1. Russia Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Breast Cancer Liquid Biopsy Market

28.1. North America Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Breast Cancer Liquid Biopsy Market

29.1. USA Breast Cancer Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Breast Cancer Liquid Biopsy Market

30.1. Canada Breast Cancer Liquid Biopsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Breast Cancer Liquid Biopsy Market

31.1. South America Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Breast Cancer Liquid Biopsy Market

32.1. Brazil Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Breast Cancer Liquid Biopsy Market

33.1. Middle East Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Breast Cancer Liquid Biopsy Market

34.1. Africa Breast Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Breast Cancer Liquid Biopsy Market, Segmentation By Product, Segmentation By Biomarkers, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Breast Cancer Liquid Biopsy Market Regulatory and Investment Landscape

36. Breast Cancer Liquid Biopsy Market Competitive Landscape And Company Profiles

36.1. Breast Cancer Liquid Biopsy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Breast Cancer Liquid Biopsy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Breast Cancer Liquid Biopsy Market Company Profiles

36.3.1. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

37. Breast Cancer Liquid Biopsy Market Other Major And Innovative Companies

Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Myriad Genetics Inc., NeoGenomics Laboratories, Guardant Health Inc., Twist Bioscience, Foundation Medicine Inc., Biodesix Inc., Menarini Silicon Biosystems, Datar Cancer Genetics, Abcam plc, OncoDNA SA, Genomic Health Inc.

38. Global Breast Cancer Liquid Biopsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Breast Cancer Liquid Biopsy Market

40. Breast Cancer Liquid Biopsy Market High Potential Countries, Segments and Strategies

40.1 Breast Cancer Liquid Biopsy Market In 2030 - Countries Offering Most New Opportunities

40.2 Breast Cancer Liquid Biopsy Market In 2030 - Segments Offering Most New Opportunities

40.3 Breast Cancer Liquid Biopsy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Breast Cancer Liquid Biopsy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Breast Cancer Liquid Biopsy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Breast Cancer Liquid Biopsy Market, Supply Chain Analysis
  • Table 4: Global Breast Cancer Liquid Biopsy Market, Major Raw Material Providers
  • Table 5: Global Breast Cancer Liquid Biopsy Market, Major Resource Providers
  • Table 6: Global Breast Cancer Liquid Biopsy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Breast Cancer Liquid Biopsy Market, Major Distributors And Channel Partners
  • Table 8: Global Breast Cancer Liquid Biopsy Market, Key Technologies & Future Trends
  • Table 9: Global Breast Cancer Liquid Biopsy Market, Major Trends
  • Table 10: Global Breast Cancer Liquid Biopsy Market, Major End Users
  • Table 11: Global Breast Cancer Liquid Biopsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Breast Cancer Liquid Biopsy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Breast Cancer Liquid Biopsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Breast Cancer Liquid Biopsy Market - TAM, US$ Billion, 2025
  • Table 15: Global Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Breast Cancer Liquid Biopsy Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Breast Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Breast Cancer Liquid Biopsy Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Breast Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Breast Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Breast Cancer Liquid Biopsy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Breast Cancer Liquid Biopsy Market - Company Scoring Matrix
  • Table 97: Johnson & Johnson Private Limited Financial Performance
  • Table 98: Roche Diagnostics Financial Performance
  • Table 99: Merck KGaA Financial Performance
  • Table 100: Thermo Fisher Scientific Financial Performance
  • Table 101: Siemens Healthineers Financial Performance
  • Table 102: Global Breast Cancer Liquid Biopsy Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Breast Cancer Liquid Biopsy Market, Competitive Dashboard
  • Table 104: Global Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 106: Global, Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Biomarkers, 2025 – 2030
  • Table 107: Global, Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Breast Cancer Liquid Biopsy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Breast Cancer Liquid Biopsy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Breast Cancer Liquid Biopsy Market, Supply Chain Analysis
  • Figure 4: Global Breast Cancer Liquid Biopsy Market, Major Raw Material Providers
  • Figure 5: Global Breast Cancer Liquid Biopsy Market, Major Resource Providers
  • Figure 6: Global Breast Cancer Liquid Biopsy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Breast Cancer Liquid Biopsy Market, Major Distributors And Channel Partners
  • Figure 8: Global Breast Cancer Liquid Biopsy Market, Key Technologies & Future Trends
  • Figure 9: Global Breast Cancer Liquid Biopsy Market, Major Trends
  • Figure 10: Global Breast Cancer Liquid Biopsy Market, Major End Users
  • Figure 11: Global Breast Cancer Liquid Biopsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Breast Cancer Liquid Biopsy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Breast Cancer Liquid Biopsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Breast Cancer Liquid Biopsy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Breast Cancer Liquid Biopsy Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Breast Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Breast Cancer Liquid Biopsy Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Breast Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Breast Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Breast Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Breast Cancer Liquid Biopsy Market, Segmentation By Biomarkers, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Breast Cancer Liquid Biopsy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Breast Cancer Liquid Biopsy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Breast Cancer Liquid Biopsy Market - Company Scoring Matrix
  • Figure 97: Johnson & Johnson Private Limited Financial Performance
  • Figure 98: Roche Diagnostics Financial Performance
  • Figure 99: Merck KGaA Financial Performance
  • Figure 100: Thermo Fisher Scientific Financial Performance
  • Figure 101: Siemens Healthineers Financial Performance
  • Figure 102: Global Breast Cancer Liquid Biopsy Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Breast Cancer Liquid Biopsy Market, Competitive Dashboard
  • Figure 104: Global Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 106: Global, Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Biomarkers, 2025 – 2030
  • Figure 107: Global, Breast Cancer Liquid Biopsy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Read More About Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Read More About Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Read More About Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Read More About Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Liquid Biopsy For Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Product, Services), By Sample (Blood, Urine, Saliva), By Cancer (Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers), By End-User (...

Liquid Biopsy Market Report 2026 - Global Outlook – By Product (Assay Kits, Instruments, Services ), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), By En...

Breast Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridizati...

Biopsy Devices Market Report 2026 - Global Outlook – By Product Type (Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products), By Image Guiding Technology (MRI-Guided Biopsy, St...

Metastatic HR+/HER2- Breast Cancer Market Report 2026 - Global Outlook – By Drugs (Paclitaxel, Tamoxifen, Docetaxel, Other Drugs), By Treatment (Radiation Therapy, Vitamin Therapy, Macrobiotic Diets, Homeopathy, Herbal M...

Breast Cancer Drugs Market Report 2026 - Global Outlook – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Othe...

Metastatic Breast Cancer Treatment Market Report 2026 - Global Outlook – By Therapy Type (Chemotherapy, Radiation Therapy, Biologic Targeted Therapy, Breast Surgery, Hormone Therapy), By Molecule Type (Monoclonal Antibod...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Frequently Asked Questions

The Breast Cancer Liquid Biopsy market was valued at $0.89 billion in 2025, increased to $1.02 billion in 2026, and is projected to reach $1.75 billion by 2030.

The global Breast Cancer Liquid Biopsy market is expected to grow at a CAGR of 14.3% from 2026 to 2035 to reach $1.75 billion by 2035.

Some Key Players in the Breast Cancer Liquid Biopsy market Include, Johnson & Johnson Private Limited, Roche Diagnostics, Merck KGaA, Thermo Fisher Scientific, Siemens Healthineers, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Myriad Genetics Inc., NeoGenomics Laboratories, Guardant Health Inc., Twist Bioscience, Foundation Medicine Inc., Biodesix Inc., Menarini Silicon Biosystems, Datar Cancer Genetics, Abcam plc, OncoDNA SA, Genomic Health Inc., RainDance Technologies, Biocept Inc., Fluxion Biosciences Inc., Angle plc .

Major trend in this market includes: Advancements In Companion Diagnostics For Personalized Cancer Treatment. For further insights on this market. request a sample here

North America was the largest region in the breast cancer liquid biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer liquid biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us